Literature DB >> 9202922

Propofol neuroprotection in a rat model of ischaemia reperfusion injury.

Y Young1, D K Menon, N Tisavipat, B F Matta, J G Jones.   

Abstract

This study was designed to test the hypothesis that propofol, which possesses antioxidant properties, would produce greater protection than isoflurane in cerebral ischaemia reperfusion injury, at dose levels that produced similar affects on brain electrical activity. Twenty Sprague-Dawley rats were anaesthetized using isoflurane 1.5% in air/oxygen, and mechanically ventilated to a PaCO2 of 4.5 kPa. Following 90 min of middle cerebral artery occlusion using an intraluminal filament, rats were given, in random order, either propofol 1 mg kg-1 min-1 or isoflurane 3% (both of which have been shown to reliably produce EEG burst suppression). After a further 30 min, reperfusion was induced by withdrawing the filament. Animals were killed following 240 min of reperfusion. Rats in the propofol group showed a 21% reduction in mean hemispheric infarct volume when compared with the isoflurane group (P < 0.0001). These data suggest that propofol may act by mechanisms in addition to CMRO2 depression, and provide a basis for further studies of propofol neuroprotection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202922     DOI: 10.1046/j.1365-2346.1997.00130.x

Source DB:  PubMed          Journal:  Eur J Anaesthesiol        ISSN: 0265-0215            Impact factor:   4.330


  15 in total

Review 1.  Comparative tolerability of sedative agents in head-injured adults.

Authors:  Susan C Urwin; David K Menon
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

2.  Propofol protects against angiotensin II-induced mouse hippocampal HT22 cells apoptosis via inhibition of p66Shc mitochondrial translocation.

Authors:  Minmin Zhu; Jiawei Chen; Meilin Wen; Zhirong Sun; Xia Sun; Jing Wang; Changhong Miao
Journal:  Neuromolecular Med       Date:  2014-08-24       Impact factor: 3.843

Review 3.  Pharmacologic neuroprotection: the search continues.

Authors:  Hilary P Grocott
Journal:  J Extra Corpor Technol       Date:  2007-12

4.  Propofol Attenuates Inflammatory Response in LPS-Activated Microglia by Regulating the miR-155/SOCS1 Pathway.

Authors:  Xinxun Zheng; Hongbing Huang; Jianjun Liu; Minghua Li; Min Liu; Tao Luo
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

Review 5.  Anesthesia in Experimental Stroke Research.

Authors:  Ulrike Hoffmann; Huaxin Sheng; Cenk Ayata; David S Warner
Journal:  Transl Stroke Res       Date:  2016-08-17       Impact factor: 6.829

6.  Endoplasmic reticulum stress is involved in the neuroprotective effect of propofol.

Authors:  Likui Wang; Weixiang Tang; Tongcui Jiang; Peng Lu; Yuanhai Li; Aimin Sun; Yujun Shen; Yin Chen; Haiping Wang; Zhijun Zong; Yiqiao Wang; Lijian Chen; Yuxian Shen
Journal:  Neurochem Res       Date:  2014-06-25       Impact factor: 3.996

Review 7.  The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties.

Authors:  Yoshinori Kotani; Masamitsu Shimazawa; Shinichi Yoshimura; Toru Iwama; Hideaki Hara
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

8.  Neuroprotective effects of propofol, thiopental, etomidate, and midazolam in fetal rat brain in ischemia-reperfusion model.

Authors:  Ferhat Harman; Askin Esen Hasturk; Mehmet Yaman; Turkan Arca; Kamer Kilinc; Mustafa Fevzi Sargon; Erkan Kaptanoglu
Journal:  Childs Nerv Syst       Date:  2012-05-05       Impact factor: 1.475

9.  Etiology of Burst Suppression EEG Patterns.

Authors:  Akshay Shanker; John H Abel; Gabriel Schamberg; Emery N Brown
Journal:  Front Psychol       Date:  2021-06-10

10.  Effect of propofol in the immature rat brain on short- and long-term neurodevelopmental outcome.

Authors:  Tanja Karen; Gerald W Schlager; Ivo Bendix; Marco Sifringer; Ralf Herrmann; Christos Pantazis; David Enot; Matthias Keller; Thoralf Kerner; Ursula Felderhoff-Mueser
Journal:  PLoS One       Date:  2013-05-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.